These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16365429)

  • 1. Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations.
    Saribasak H; Saribasak NN; Ipek FM; Ellwart JW; Arakawa H; Buerstedde JM
    J Immunol; 2006 Jan; 176(1):365-71. PubMed ID: 16365429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced cytidine deaminase-mediated hypermutation in the DT40 cell line.
    Arakawa H; Buerstedde JM
    Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):639-44. PubMed ID: 19008193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Ig gene hypermutation in Ung(-/-)Polh(-/-) mice suggests that UNG and A:T mutagenesis pathway target different U:G lesions.
    Li S; Zhao Y; Wang JY
    Mol Immunol; 2013 Mar; 53(3):214-7. PubMed ID: 22960197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The very 5' end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions.
    Longerich S; Tanaka A; Bozek G; Nicolae D; Storb U
    J Exp Med; 2005 Nov; 202(10):1443-54. PubMed ID: 16301749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contested role of uracil DNA glycosylase in immunoglobulin gene diversification.
    Longerich S; Storb U
    Trends Genet; 2005 May; 21(5):253-6. PubMed ID: 15851057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion.
    Arakawa H; Hauschild J; Buerstedde JM
    Science; 2002 Feb; 295(5558):1301-6. PubMed ID: 11847344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase.
    Di Noia J; Neuberger MS
    Nature; 2002 Sep; 419(6902):43-8. PubMed ID: 12214226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination.
    Di Noia JM; Neuberger MS
    Eur J Immunol; 2004 Feb; 34(2):504-8. PubMed ID: 14768055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil.
    Kavli B; Andersen S; Otterlei M; Liabakk NB; Imai K; Fischer A; Durandy A; Krokan HE; Slupphaug G
    J Exp Med; 2005 Jun; 201(12):2011-21. PubMed ID: 15967827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chicken MBD4 Regulates Immunoglobulin Diversification by Somatic Hypermutation.
    Costello R; Cantillo JF; Kenter AL
    Front Immunol; 2019; 10():2540. PubMed ID: 31736964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID preferentially targets the top strand in nucleosome sequences.
    Singh AK; Jaiswal A; Kodgire P
    Mol Immunol; 2019 Aug; 112():198-205. PubMed ID: 31176199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pms2 and uracil-DNA glycosylases act jointly in the mismatch repair pathway to generate Ig gene mutations at A-T base pairs.
    Girelli Zubani G; Zivojnovic M; De Smet A; Albagli-Curiel O; Huetz F; Weill JC; Reynaud CA; Storck S
    J Exp Med; 2017 Apr; 214(4):1169-1180. PubMed ID: 28283534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil in DNA--general mutagen, but normal intermediate in acquired immunity.
    Kavli B; Otterlei M; Slupphaug G; Krokan HE
    DNA Repair (Amst); 2007 Apr; 6(4):505-16. PubMed ID: 17116429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Ig gene somatic hypermutation in the absence of activation-induced cytidine deaminase.
    Longo NS; Satorius CL; Plebani A; Durandy A; Lipsky PE
    J Immunol; 2008 Jul; 181(2):1299-306. PubMed ID: 18606684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of somatic hypermutations in the IgM switch region in human B cells.
    Horiuchi K; Imai K; Mitsui-Sekinaka K; Yeh TW; Ochs HD; Durandy A; Nonoyama S
    J Allergy Clin Immunol; 2014 Aug; 134(2):411-9. PubMed ID: 24836470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BRCT domain of PARP-1 is required for immunoglobulin gene conversion.
    Paddock MN; Buelow BD; Takeda S; Scharenberg AM
    PLoS Biol; 2010 Jul; 8(7):e1000428. PubMed ID: 20652015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-strand DNA breaks in Ig class switch recombination that depend on UNG but not AID.
    Arudchandran A; Bernstein RM; Max EE
    Int Immunol; 2008 Nov; 20(11):1381-93. PubMed ID: 18794203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate.
    Arakawa H; Saribasak H; Buerstedde JM
    PLoS Biol; 2004 Jul; 2(7):E179. PubMed ID: 15252444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brca1 in immunoglobulin gene conversion and somatic hypermutation.
    Longerich S; Orelli BJ; Martin RW; Bishop DK; Storb U
    DNA Repair (Amst); 2008 Feb; 7(2):253-66. PubMed ID: 18036997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.